Search

everythinglearnresearchcommunity

for

Search:↓

PLD is an effective and safer alternative for treating breast cancer.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

A blood pressure drug, diltiazem, may also help treat influenza.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The botanical treatment for hair loss shows promise, especially for children.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Blocking a protein called prostaglandin D2 might help treat hair loss.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.